CRBU
Price
$1.64
Change
-$0.00 (-0.00%)
Updated
Jun 18 closing price
Capitalization
162.66M
51 days until earnings call
Intraday BUY SELL Signals
MGX
Price
$1.20
Change
+$0.02 (+1.69%)
Updated
Jun 18 closing price
Capitalization
45.18M
58 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRBU vs MGX

CRBU vs MGX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CRBU vs. MGX commentary
Jun 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Hold and MGX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 22, 2026
Stock price -- (CRBU: $1.64 vs. MGX: $1.20)
Brand notoriety: CRBU and MGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 142% vs. MGX: 107%
Market capitalization -- CRBU: $162.66M vs. MGX: $45.18M
CRBU [@Biotechnology] is valued at $162.66M. MGX’s [@Biotechnology] market capitalization is $45.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.63B to $0. The average market capitalization across the [@Biotechnology] industry is $1.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileMGX’s FA Score has 1 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • MGX’s FA Score: 1 green, 4 red.
According to our system of comparison, CRBU is a better buy in the long-term than MGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 4 TA indicator(s) are bullish while MGX’s TA Score has 4 bullish TA indicator(s).

  • CRBU’s TA Score: 4 bullish, 6 bearish.
  • MGX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MGX is a better buy in the short-term than CRBU.

Price Growth

CRBU (@Biotechnology) experienced а -1.20% price change this week, while MGX (@Biotechnology) price change was -4.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.61%. For the same industry, the average monthly price growth was +8.78%, and the average quarterly price growth was +2225.89%.

Reported Earning Dates

CRBU is expected to report earnings on Aug 12, 2026.

MGX is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (+2.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBU($163M) has a higher market cap than MGX($45.2M). CRBU YTD gains are higher at: 3.145 vs. MGX (-25.926). MGX has higher annual earnings (EBITDA): -87.55M vs. CRBU (-116.43M). MGX has more cash in the bank: 140M vs. CRBU (118M). CRBU has less debt than MGX: CRBU (26.9M) vs MGX (39.2M). MGX has higher revenues than CRBU: MGX (22.3M) vs CRBU (11.2M).
CRBUMGXCRBU / MGX
Capitalization163M45.2M361%
EBITDA-116.43M-87.55M133%
Gain YTD3.145-25.926-12%
P/E RatioN/AN/A-
Revenue11.2M22.3M50%
Total Cash118M140M84%
Total Debt26.9M39.2M69%
TECHNICAL ANALYSIS
Technical Analysis
CRBUMGX
RSI
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
88%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
84%
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signal:
Gain/Loss:
MGX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ETNHX50.180.63
+1.27%
Eventide Healthcare & Life Sciences N
FSANX18.850.20
+1.07%
Fidelity Asset Manager 60%
VESAX21.330.17
+0.80%
VELA Small Cap A
QDISX21.220.12
+0.57%
FI Instl Group Stock for Ret Plns
FIUSX38.820.17
+0.44%
Nomura Opportunity A

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with EDIT. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
N/A
EDIT - CRBU
64%
Loosely correlated
+5.49%
CRSP - CRBU
59%
Loosely correlated
+1.88%
RXRX - CRBU
56%
Loosely correlated
+3.86%
SANA - CRBU
53%
Loosely correlated
+3.62%
BEAM - CRBU
51%
Loosely correlated
+5.11%
More

MGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGX has been loosely correlated with PRME. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MGX jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGX
1D Price
Change %
MGX100%
+1.69%
PRME - MGX
50%
Loosely correlated
+2.22%
EDIT - MGX
49%
Loosely correlated
+5.49%
CRBU - MGX
49%
Loosely correlated
N/A
RXRX - MGX
49%
Loosely correlated
+3.86%
VYGR - MGX
46%
Loosely correlated
+2.76%
More